Dorman, K., Boeck, S., Snijder, R. J., Siveke, J. T., Schenk, M., Mayerle, J., . . . Heinemann, V. (2023). Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current Oncology, 30(6), 5828. https://doi.org/10.3390/curroncol30060436
Chicago Style (17th ed.) CitationDorman, Klara, et al. "Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer." Current Oncology 30, no. 6 (2023): 5828. https://doi.org/10.3390/curroncol30060436.
MLA (9th ed.) CitationDorman, Klara, et al. "Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer." Current Oncology, vol. 30, no. 6, 2023, p. 5828, https://doi.org/10.3390/curroncol30060436.